Mark Ragosa Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity

KNSA Quotes by TradingView

Mark Ragosa is CHIEF FINANCIAL OFFICER of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 22,958 shares of KNSA, which is worth approximately $457,782. The most recent transaction as insider was on Dec 09, 2024, when has been sold 18,860 shares (Class A Ordinary Share) at a price of $21.38 per share, resulting in proceeds of $403,226. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23K
0% 3M change
46.87% 12M change
Total Value Held $457,782

Mark Ragosa Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 09 2024
SELL
Open market or private sale
$403,226 $21.38 p/Share
18,860 Reduced 45.1%
22,958 Class A Ordinary Share
Dec 09 2024
BUY
Exercise of conversion of derivative security
$209,346 $11.1 p/Share
18,860 Added 31.08%
41,818 Class A Ordinary Share
Dec 06 2024
SELL
Open market or private sale
$190,770 $21.27 p/Share
8,969 Reduced 28.09%
22,958 Class A Ordinary Share
Dec 06 2024
BUY
Exercise of conversion of derivative security
$25,888 $10.76 p/Share
2,406 Added 8.66%
25,364 Class A Ordinary Share
Dec 05 2024
SELL
Open market or private sale
$23,863 $21.25 p/Share
1,123 Reduced 4.66%
22,958 Class A Ordinary Share
Dec 05 2024
BUY
Exercise of conversion of derivative security
$12,083 $10.76 p/Share
1,123 Added 4.46%
24,081 Class A Ordinary Share
Dec 04 2024
SELL
Open market or private sale
$106,760 $21.25 p/Share
5,024 Reduced 17.95%
22,958 Class A Ordinary Share
Dec 04 2024
BUY
Exercise of conversion of derivative security
$54,058 $10.76 p/Share
5,024 Added 15.22%
27,982 Class A Ordinary Share
Dec 03 2024
SELL
Open market or private sale
$192,385 $21.45 p/Share
8,969 Reduced 28.09%
22,958 Class A Ordinary Share
Dec 03 2024
BUY
Exercise of conversion of derivative security
$96,506 $10.76 p/Share
8,969 Added 21.93%
31,927 Class A Ordinary Share
Sep 02 2024
SELL
Payment of exercise price or tax liability
$25,563 $26.74 p/Share
956 Reduced 4.0%
22,958 Class A Ordinary Share
Sep 02 2024
BUY
Exercise of conversion of derivative security
-
1,861 Added 7.22%
23,914 Class A Ordinary Share
Sep 01 2024
SELL
Payment of exercise price or tax liability
$60,432 $26.74 p/Share
2,260 Reduced 9.3%
22,053 Class A Ordinary Share
Sep 01 2024
BUY
Exercise of conversion of derivative security
-
4,444 Added 15.45%
24,313 Class A Ordinary Share
Jul 23 2024
SELL
Open market or private sale
$601,107 $24.79 p/Share
24,248 Reduced 55.74%
19,253 Class A Ordinary Share
Jul 23 2024
BUY
Exercise of conversion of derivative security
$269,152 $11.1 p/Share
24,248 Added 35.79%
43,501 Class A Ordinary Share
Apr 26 2024
SELL
Payment of exercise price or tax liability
$9,100 $17.88 p/Share
509 Reduced 2.58%
19,253 Class A Common Share
Apr 26 2024
BUY
Exercise of conversion of derivative security
-
991 Added 4.78%
19,762 Class A Common Share
Apr 08 2024
SELL
Payment of exercise price or tax liability
$14,158 $17.9 p/Share
791 Reduced 4.04%
18,771 Class A Common Share
Apr 08 2024
BUY
Exercise of conversion of derivative security
-
2,694 Added 12.1%
19,562 Class A Common Share
Apr 01 2024
SELL
Payment of exercise price or tax liability
$10,125 $19.7 p/Share
514 Reduced 2.96%
16,868 Class A Common Share
Apr 01 2024
BUY
Exercise of conversion of derivative security
-
1,750 Added 9.15%
17,382 Class A Common Share
Jan 03 2024
SELL
Open market or private sale
$240,000 $20.0 p/Share
12,000 Reduced 43.43%
15,632 Class A Common Share
Jan 03 2024
BUY
Exercise of conversion of derivative security
$105,960 $8.83 p/Share
12,000 Added 30.28%
27,632 Class A Common Share
Sep 02 2023
SELL
Payment of exercise price or tax liability
$9,714 $17.76 p/Share
547 Reduced 3.38%
15,632 Class A Common Share
MR

Mark Ragosa

CHIEF FINANCIAL OFFICER
Hamilton, D0

Track Institutional and Insider Activities on KNSA

Follow Kiniksa Pharmaceuticals, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KNSA